Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1964 1
1965 1
1966 1
1968 1
1987 2
1988 1
1989 1
1990 1
1993 4
1994 2
1995 4
1997 12
1998 2
1999 7
2000 6
2001 5
2002 6
2003 11
2004 12
2005 10
2006 20
2007 15
2008 17
2009 31
2010 23
2011 15
2012 13
2013 12
2014 19
2015 20
2016 16
2017 20
2018 20
2019 19
2020 21
2021 31
2022 30
2023 22
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

418 results

Results by year

Filters applied: . Clear all
Page 1
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. Among authors: di fiore f. N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775. N Engl J Med. 2018. PMID: 30575490 Clinical Trial.
Selective STING stimulation in dendritic cells primes antitumor T cell responses.
Jneid B, Bochnakian A, Hoffmann C, Delisle F, Djacoto E, Sirven P, Denizeau J, Sedlik C, Gerber-Ferder Y, Fiore F, Akyol R, Brousse C, Kramer R, Walters I, Carlioz S, Salmon H, Malissen B, Dalod M, Piaggio E, Manel N. Jneid B, et al. Among authors: fiore f. Sci Immunol. 2023 Jan 13;8(79):eabn6612. doi: 10.1126/sciimmunol.abn6612. Epub 2023 Jan 13. Sci Immunol. 2023. PMID: 36638189
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.
Walter T, Lievre A, Coriat R, Malka D, Elhajbi F, Di Fiore F, Hentic O, Smith D, Hautefeuille V, Roquin G, Perrier M, Dahan L, Granger V, Sobhani I, Mineur L, Niccoli P, Assenat E, Scoazec JY, Le Malicot K, Lepage C, Lombard-Bohas C. Walter T, et al. Among authors: di fiore f. Lancet Oncol. 2023 Mar;24(3):297-306. doi: 10.1016/S1470-2045(23)00001-3. Epub 2023 Feb 2. Lancet Oncol. 2023. PMID: 36739879 Clinical Trial.
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives.
Ottaiano A, Santorsola M, Circelli L, Trotta AM, Izzo F, Perri F, Cascella M, Sabbatino F, Granata V, Correra M, Tarotto L, Stilo S, Fiore F, Martucci N, Rocca A, Picone C, Muto P, Borzillo V, Belli A, Patrone R, Mercadante E, Tatangelo F, Ferrara G, Di Mauro A, Scognamiglio G, Berretta M, Capuozzo M, Lombardi A, Galon J, Gualillo O, Pace U, Delrio P, Savarese G, Scala S, Nasti G, Caraglia M. Ottaiano A, et al. Among authors: fiore f. Cancers (Basel). 2023 Mar 17;15(6):1827. doi: 10.3390/cancers15061827. Cancers (Basel). 2023. PMID: 36980713 Free PMC article. Review.
[Aspirin and colorectal cancer].
Grancher A, Michel P, Di Fiore F, Sefrioui D. Grancher A, et al. Among authors: di fiore f. Bull Cancer. 2018 Feb;105(2):171-180. doi: 10.1016/j.bulcan.2017.09.013. Epub 2017 Nov 15. Bull Cancer. 2018. PMID: 29153543 Review. French.
ESR1 mutations in breast cancer.
Clatot F, Augusto L, Di Fiore F. Clatot F, et al. Among authors: di fiore f. Aging (Albany NY). 2017 Jan 25;9(1):3-4. doi: 10.18632/aging.101165. Aging (Albany NY). 2017. PMID: 28130553 Free PMC article. No abstract available.
TERT Promoter Alterations in Glioblastoma: A Systematic Review.
Olympios N, Gilard V, Marguet F, Clatot F, Di Fiore F, Fontanilles M. Olympios N, et al. Among authors: di fiore f. Cancers (Basel). 2021 Mar 8;13(5):1147. doi: 10.3390/cancers13051147. Cancers (Basel). 2021. PMID: 33800183 Free PMC article. Review.
Colorectal cancer chemoprevention: is aspirin still in the game?
Grancher A, Michel P, Di Fiore F, Sefrioui D. Grancher A, et al. Among authors: di fiore f. Cancer Biol Ther. 2022 Dec 31;23(1):446-461. doi: 10.1080/15384047.2022.2104561. Cancer Biol Ther. 2022. PMID: 35905195 Free PMC article. Review.
418 results